Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 4/2017

01-04-2017 | General Gynecology

Management of device-related complications after sacral neuromodulation for lower urinary tract disorders in women: a single center experience

Authors: Tilemachos Kavvadias, Markus Huebner, Sara Yvonne Brucker, Christl Reisenauer

Published in: Archives of Gynecology and Obstetrics | Issue 4/2017

Login to get access

Abstract

Purpose

This study is aimed at presenting and discussing the device-related complication management during a 5-year period, of the sacral nerve modulation (SNM), in a tertiary-care university unit.

Methods

This is a retrospective chart review of all women, who received SNM in our department between May 2011 and May 2016. All two-stage procedures were performed by the same experienced surgeon and according to our strict protocol of patients’ selection and follow-up. Data of perioperative and postoperative complications and their management were collected.

Results

The test stimulation was positive in 59 out of 64 patients (92%), who then received the permanent implantation after a mean test phase duration of 9 days. Mean overall follow-up was 16.5 (±10.9) months. We recorded 20 complications (31%) in 15 patients, after a mean follow-up time of 160 days. These comprise: lead migration (13.8%), infection (8.6%), pain (5.2%), wound healing disorders (5.2%) and lead fibrosis (10%). The event/patient ratio was significantly reduced from 0.6 in the beginning of our experience with SNM to 0.2 at the second period of the study (p = 0.005). All complications could be successfully resolved after surgical intervention without influence on the treatment effect.

Conclusion

Complications after SNM are common and may require additional surgical intervention for full resolution but without affecting the treatment effect. Also, due to a learning curve, a lower events/patient ratio over time is to be expected.
Literature
1.
go back to reference Apostolidis A (2011) Neuromodulation for intractable OAB. Neurourol Urodynam 30:766–770CrossRef Apostolidis A (2011) Neuromodulation for intractable OAB. Neurourol Urodynam 30:766–770CrossRef
2.
3.
go back to reference Brazzelli M, Murray A, Fraser C (2006) Efficacy and safety of sacral nerve stimulation for urinary urge incontinence; a systematic review. J Urol 175:835–841CrossRefPubMed Brazzelli M, Murray A, Fraser C (2006) Efficacy and safety of sacral nerve stimulation for urinary urge incontinence; a systematic review. J Urol 175:835–841CrossRefPubMed
4.
go back to reference Peeters K, Sahai A, De Ridder D, Van Der Aa F (2014) Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction. BJU Int 113:789–794CrossRefPubMed Peeters K, Sahai A, De Ridder D, Van Der Aa F (2014) Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction. BJU Int 113:789–794CrossRefPubMed
5.
go back to reference Cappellano F, Bertapelle P, Spinelli M, Catanzaro F, Carone R, Zanollo A, De Seta F, Giardiello G (2001) Quality of life assessment in patients who undergo sacral neuromodulation implantation for urge incontinence: an additional tool for evaluating outcome. J Urol 166(6):2277–2280CrossRefPubMed Cappellano F, Bertapelle P, Spinelli M, Catanzaro F, Carone R, Zanollo A, De Seta F, Giardiello G (2001) Quality of life assessment in patients who undergo sacral neuromodulation implantation for urge incontinence: an additional tool for evaluating outcome. J Urol 166(6):2277–2280CrossRefPubMed
7.
go back to reference Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Kan F, Thiery E (2016) Three-year follow-up results of a prospective, multicenter study in overactive bladder subjects treated with sacral neuromodulation. Urology. doi:10.1016/j.urology.2016.04.024 Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Kan F, Thiery E (2016) Three-year follow-up results of a prospective, multicenter study in overactive bladder subjects treated with sacral neuromodulation. Urology. doi:10.​1016/​j.​urology.​2016.​04.​024
8.
go back to reference Peters KM, Killinger KA, Gilleran JP, Bartley J, Wolfert C, Boura JA (2015) Predictors of reoperation after sacral neuromodulation: a single institution evaluation of over 400 patients. Neurourol Urodyn. doi:10.1002/nau.22929 Peters KM, Killinger KA, Gilleran JP, Bartley J, Wolfert C, Boura JA (2015) Predictors of reoperation after sacral neuromodulation: a single institution evaluation of over 400 patients. Neurourol Urodyn. doi:10.​1002/​nau.​22929
9.
go back to reference Gormley EA, Lightner DJ, Faraday M, Vasavada SP (2015) Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 193:1572–1580CrossRefPubMed Gormley EA, Lightner DJ, Faraday M, Vasavada SP (2015) Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 193:1572–1580CrossRefPubMed
10.
go back to reference Siegel SW, Catanzaro F, Dijkema HE, Elhilali MM, Fowler CJ, Gajewski JB, Hassouna MM, Janknegt RA, Jonas U, Van Kerrebroeck PE, Lycklama a Nijeholt AA, Oleson KA, Schmidt RA (2000) Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency and retention. Urology 56(6 Suppl 1):87–91CrossRefPubMed Siegel SW, Catanzaro F, Dijkema HE, Elhilali MM, Fowler CJ, Gajewski JB, Hassouna MM, Janknegt RA, Jonas U, Van Kerrebroeck PE, Lycklama a Nijeholt AA, Oleson KA, Schmidt RA (2000) Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency and retention. Urology 56(6 Suppl 1):87–91CrossRefPubMed
11.
go back to reference Siddiqui N, Amundsen C, Corey E, Wu J (2011) Lead migration after sacral neuromodulation: surgical revision in fascial versus tined anchoring systems. Int Urogynecol J 22:419–423CrossRefPubMed Siddiqui N, Amundsen C, Corey E, Wu J (2011) Lead migration after sacral neuromodulation: surgical revision in fascial versus tined anchoring systems. Int Urogynecol J 22:419–423CrossRefPubMed
12.
go back to reference Al-Zahrani A, Elzayat E, Gajewski J (2011) Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms: 14-year experience at 1 center. J Urol 185:981–986CrossRefPubMed Al-Zahrani A, Elzayat E, Gajewski J (2011) Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms: 14-year experience at 1 center. J Urol 185:981–986CrossRefPubMed
13.
go back to reference Van Voskuilen AC, Oerlemans DJ, Weil EH et al (2006) Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. Eur Urol 49:366–372CrossRefPubMed Van Voskuilen AC, Oerlemans DJ, Weil EH et al (2006) Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. Eur Urol 49:366–372CrossRefPubMed
14.
go back to reference Gaynor-Krupnick D, Dwyer N, Rittenmeyer H, Kreder K (2006) Evaluation and management of malfunctioning sacral neuromodulator. Urology 67:246–249CrossRefPubMed Gaynor-Krupnick D, Dwyer N, Rittenmeyer H, Kreder K (2006) Evaluation and management of malfunctioning sacral neuromodulator. Urology 67:246–249CrossRefPubMed
15.
go back to reference Wexner S, Hull T, Edden Y, Coller J, Devroede G, McCallum, Chan M, Ayscue J, Shobeiri A, Margolin D, England M, Kaufman H, Snape W, Mutlu E, Chua H, Pettit P, Nagle D, Madoff R, Lerew D, Mellgren D (2010) Infection rates in a large investigational trial of sacral nerve stimulation for fecal incontinence. J Gastrointest Surg 14:1081–1089CrossRefPubMed Wexner S, Hull T, Edden Y, Coller J, Devroede G, McCallum, Chan M, Ayscue J, Shobeiri A, Margolin D, England M, Kaufman H, Snape W, Mutlu E, Chua H, Pettit P, Nagle D, Madoff R, Lerew D, Mellgren D (2010) Infection rates in a large investigational trial of sacral nerve stimulation for fecal incontinence. J Gastrointest Surg 14:1081–1089CrossRefPubMed
16.
go back to reference Hijaz A, Vasavada S, Daneshgari F, Frinjari, Goldman H, Rackley R (2006) Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience. Urology 68:533–537CrossRefPubMed Hijaz A, Vasavada S, Daneshgari F, Frinjari, Goldman H, Rackley R (2006) Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience. Urology 68:533–537CrossRefPubMed
17.
go back to reference White WM, Mobley JD III, Doggweiler R, Dobmeyer-Dittrich C, Klein FA (2009) Incidence and predictors of complications with sacral neuromodulation. Urology 73:731–735CrossRefPubMed White WM, Mobley JD III, Doggweiler R, Dobmeyer-Dittrich C, Klein FA (2009) Incidence and predictors of complications with sacral neuromodulation. Urology 73:731–735CrossRefPubMed
Metadata
Title
Management of device-related complications after sacral neuromodulation for lower urinary tract disorders in women: a single center experience
Authors
Tilemachos Kavvadias
Markus Huebner
Sara Yvonne Brucker
Christl Reisenauer
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 4/2017
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4303-2

Other articles of this Issue 4/2017

Archives of Gynecology and Obstetrics 4/2017 Go to the issue